Exercise boosts cancer recovery and slashes risk of death or relapse by a third, major study finds
'BETTER THAN A DRUG' Exercise boosts cancer recovery and slashes risk of death or relapse by a third, major study finds
EXERCISE is 'better than a drug' at stopping cancer coming back, a landmark trial suggests.
Top doctors say recovering patients should be prescribed personal trainers to boost survival.
Advertisement
1
People only needed to walk for three to four hours per week to slash their risk of dying (stock image)
Credit: Alamy
A Cancer Research UK study showed it could slash bowel cancer patients' risk of death or relapse.
Following an exercise programme after treatment reduced their risk of dying within eight years by 37 per cent.
And it reduced the chance of a patient's cancer growing back within five years by 28 per cent.
Physical activity also appeared to cut the risk for breast and prostate cancers, the two most common types.
Advertisement
'Drugs are approved for less'
Dr Julie Gralow, president of the American Society of Clinical Oncology, said: 'This is the same magnitude of benefit as many drugs.
'Drugs get approved for less than that and they're expensive and toxic, so I would say it's better than a drug.'
Dr Pamela Kunz, of Yale University in the US, said prescribing it was a 'no-brainer'.
The world-first trial involved 889 people from Canada and Australia who had received surgery and chemotherapy for colon cancer, the most common form of bowel cancer.
Advertisement
It affects around 32,000 people per year in the UK and develops in the large intestine.
Half of the participants were given basic exercise advice and the other half were assigned personal trainers and given tailored exercise programmes for three years.
Sun Health Explainer: Bowel Cancer
The plan added the equivalent of three to four hours of walking on top of patients' normal daily activity.
At the end of the 15-year trial, people in the personal trainer group were significantly less likely to have relapsed or died.
Advertisement
Study author Dr Christopher Booth, from Queen's University in Kingston, Canada, said: 'These results are clear: an exercise program that includes a personal trainer will reduce the risk of recurrent or new cancer, make you feel better and help you live longer.
'Most patients chose a walking program and could reach their targets by going for a walk of 45 to 60 minutes three to four times per week.
'The benefit was substantial and in some cases exceeded the benefit of many of our very good medical therapies.
'This sets a new standard of care for colon cancer.'
Advertisement
If you start exercising after you get through your treatment you still get the benefits – it's not too late
Dr Julie Gralow
He said that one life was saved for every 14 patients who enlisted in the exercise programme.
It cost an estimated £2,500 per patient over three years and the Canadian government is now looking at including it in hospital care.
Dr Gralow added: 'If you start exercising after you get through your treatment you absolutely still get the benefits – it's not too late.
'Three decades ago it was still the era of doctors being gentle and saying don't overdo it, but we've reversed that and had a major shift in understanding the importance of physical activity.
Advertisement
'We should be doing all we can to help patients be active.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 hours ago
- The Independent
Study finds common dietary supplement can flush out toxic forever chemicals from your body
Eating a fibre supplement derived from oats before each meal could flush out toxic forever chemicals from the body, a new study suggests. Per and polyfluoroalkyl substances, or PFAS, commonly known as forever chemicals, are widely used to make products like non-stick cookware, cosmetics, stain-resistant fabrics, firefighting foams, food packaging, and waterproof clothing. They persist in the environment for hundreds of years and are increasingly linked to a range of health conditions in humans, including decreased fertility, developmental delays in children, and a higher risk of some cancers. Scientists have been seeking ways to remove them from the body and the environment or degrade them into harmless compounds. 'Despite the growing concerns about the toxicity of PFAS, specific interventions to reduce PFAS levels in the body are limited,' the study notes. 'Current clinical treatments to reduce PFAS body burden are minimal.' Previous studies have shown that beta-glucan fibre molecules found in oats, barley and rye can bind to PFAS in the digestive system. The latest study, published in Environmental Health, finds that consuming a dietary supplement with beta-glucan fibre could significantly reduce PFAS levels in the body. Researchers recruited 72 Canadian men aged 18 to 65 with detectable levels of PFAS in their blood and fed 42 of them a diet supplement of one gram of oat beta-glucan, a type of soluble gel-forming fibre, before each mealtime, when the body produced the most bile. The remaining 30 participants received a placebo made of rice. 'Serum samples were collected from 72 participants in 2019-2020 at baseline and after four weeks of the intervention and were analysed for 17 PFASs,' the study states. After four weeks, researchers found a nearly 10 per cent drop in two of the most dangerous PFAS types in people who took the oat fibre supplement. The two forever chemicals, known as PFOA and PFOS, have been detected in drinking water, food packaging and cosmetics, and they can build up in the body over time. Although the results are modest, scientists say the findings offer a first step to formulating a dietary intervention for removing PFAS from the body. 'Results from this pilot analysis suggest a potentially practical and feasible intervention that may reduce human body burdens for some PFASs,' they say. 'However, studies utilising a larger sample with a broader range of serum concentrations, longer intervention period and clinically relevant fibre intakes are needed to determine the efficacy of using gel-forming dietary fibres to increase PFAS excretion.'
ITV News
3 hours ago
- ITV News
Cancer death rates down more than 20% in last 50 years but cases rising
Cancer death rates have fallen by more than a fifth in the last 50 years but cases are rising, according to a new analysis. A report from Cancer Research UK found people are now more likely to get cancer than decades ago, but are less likely to die from the disease. Figures show that the rate of people dying from cancer in the UK has fallen by around 22% since the early 1970s, but the rate of people being diagnosed with the disease has risen by almost half. In 1973, some 328 per 100,000 people died from cancer, dropping to around 252 per 100,000 in 2023, driven by improvements in areas such as diagnosis and better treatment, as well as action to cut smoking. The study said: 'Survival for all cancers combined in England and Wales has doubled since the early 1970s, but progress has slowed over the last 10 years and remains lower than other comparable countries. 'Survival increased three to five times faster in previous decades, compared with the improvement since 2010.' Cancer Research UK warned that, despite improvement in overall survival, many more people are being diagnosed with cancer compared with 50 years ago. Incidence rates have risen sharply by almost half (47%) across Great Britain over this period, from around 413 cases per 100,000 people to around 607 cases per 100,000 people. The report listed the preventable causes of cancer, saying smoking remains the biggest cause of cancer, while obesity is linked to 13 different types of the disease. Other risks include not using sunscreen or failing to cover up in the sun, sunbeds, alcohol, lack of exercise and diets high in processed meat. The report pointed out that around half of all new cancer diagnoses are in people aged 70 and over, but incidence rates are currently rising fastest in younger people. It said: 'In the UK, cancer incidence rates have increased by 23% in people aged 20 to 49 since the early 1990s. 'However, population growth is concentrated in older age groups, so in terms of patient numbers, the biggest increase in cancer cases has been in older people.' The study also found that, on average, just over half of cancers are diagnosed at an early stage in England (54%), and this proportion has not changed for almost a decade. Michelle Mitchell, Cancer Research UK's chief executive, said: 'It's fantastic to see that thanks to research, cancer death rates have drastically reduced over the last 50 years, and survival has doubled. 'However, there's more that can be done. This report highlights that over 460 people die from cancer every single day in the UK, and too many cases are diagnosed at a late stage. 'If we want to change that, we need bold action from the UK Government. 'The upcoming National Cancer Plan for England must improve cancer survival, and transform cancer services. 'If this plan is done right, it could save countless lives across England and ensure people affected by cancer live longer, better lives.' Cancer Research UK is calling for commitments such as the national rollout of a targeted lung cancer screening programme, quicker access to diagnostic tests for all patients, better access to GPs for speedy diagnosis and action to improve cancer waiting times. Its new study is the first ever to include 50 years of cancer death and incidence data for the UK. Elsewhere, MPs and members of the House of Lords have urged the Government to prioritise faster diagnosis of less survivable cancers, which are those that develop in the brain, pancreas, liver, lung, oesophagus and stomach. A new report from the All-Party Parliamentary Group (APPG) on Less Survivable Cancers claims these cancers claim 67,000 lives a year, around 42% of cancer deaths. Doubling diagnoses rates in these areas could save an additional 7,500 lives a year, it said. Paulette Hamilton, chairwoman of the APPG on Less Survivable Cancers, said this is a 'crucial moment for transforming patient outcomes and accelerating survival rates for the less survivable cancers'. 'We're on the brink of research breakthroughs and in the midst of developing potentially game-changing Government health reforms,' she added. 'In this backdrop, achieving faster diagnosis for these devastating cancers is finally within reach.' Professor Peter Johnson, NHS national clinical director for cancer, said: 'The NHS is seeing and treating record numbers of people for cancer, with more people diagnosed at an earlier stage than ever before, and survival rates in England at an all-time high. 'We have developed world-leading programmes, including lung cancer screening in convenient locations such as car parks and using AI to spot skin cancer, making it easier than ever before to get checked. 'The latest data shows that more than three quarters of people received the all-clear or a definitive cancer diagnosis within four weeks of an NHS urgent cancer referral.'
The Guardian
3 hours ago
- The Guardian
UK cancer survival rate doubles since 1970s amid ‘golden age', report says
The proportion of people surviving cancer in the UK has doubled since the 1970s amid a 'golden age' of progress in diagnosis and treatment, a report says. Half of those diagnosed will now survive for 10 years or more, up from 24%, according to the first study of 50 years of data on cancer mortality and cases. The rate of people dying from cancer has fallen by 23% since the 1970s, from 328 in every 100,000 people to 252. But cancer remains the UK's biggest killer, the report by Cancer Research UK (CRUK) says. Progress has not been equal across all cancers, and women have not reaped as many benefits as men. There have been greater improvements in survival for men since the 1970s but survival remains higher in women. Sustained pressure in the NHS means patients wait too long to get diagnosed and start treatment. In England, only about half of cancers are diagnosed at an early stage, and this proportion has not improved for almost a decade, the 42-page study found. The research will be published on Tuesday, the final day of the world's largest cancer conference, the annual meeting of the American Society of Clinical Oncology in Chicago. The CRUK chief executive, Michelle Mitchell, said: 'Over the last 50 years, the proportion of the population dying from cancer has fallen by more than a fifth because of life-saving research into new ways to prevent people developing the disease, detect it earlier when they do and develop new cutting-edge treatments. 'Yet cancer remains the UK's biggest killer, causing around one in four deaths in the UK – far more than other disease groups. For people affected by cancer, this means lost time and fewer precious moments with loved ones. 'As this report sets out, it is a time of both optimism and realism. We're in a golden age for cancer research, with advances in digital, genomics, data science and AI reimagining what's possible and bringing promise for current and future generations. 'However, despite the best efforts of NHS staff, patients are waiting too long for diagnosis and treatment, and cancer survival is improving at its slowest rate in the last 50 years. This is not acceptable.' Sign up to First Edition Our morning email breaks down the key stories of the day, telling you what's happening and why it matters after newsletter promotion Cancer cases would increase, not decline, if trends continued, Mitchell said. 'Nearly one in two people in the UK will get cancer in their lifetime and our projections suggest that the number of new cancer cases in the UK will rise by almost a third to over half a million every year by 2040.' The report highlights that more than 460 people die from cancer every day in the UK. 'If we want to change that, we need bold action from the UK government,' Mitchell said. A Department of Health and Social Care spokesperson said: 'It's promising to see a significant drop in cancer mortality rates, but we know there is still more work to be done. Our Plan for Change is already making an impact, with 90,000 extra patients having cancer diagnosed or ruled out since July than in the previous year – and the highest ever proportion of patients getting a diagnosis or an all-clear within four weeks in February.'
